T2 Biosystems Dividends and Buybacks
Dividend criteria checks 0/6
T2 Biosystems does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-160.8%
Buyback Yield
| Total Shareholder Yield | -160.8% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Insufficient Growth At T2 Biosystems, Inc. (NASDAQ:TTOO) Hampers Share Price
Apr 18
T2 Biosystems to develop, commercialize diagnostic test for early Lyme disease
Oct 13T2 Biosystems announces BARDA exercise of contract option 3 valued at $3.7M
Sep 29T2 Biosystems stock rises ~17% after hours on Baltic region distribution agreement
Sep 22T2 Biosystems' Survival Riddle
Aug 26T2 Biosystems Q2 2022 Earnings Preview
Aug 12T2 Biosystems drops 4% on Q2 guidance and 2022 outlook
Jul 06Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if TTOO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TTOO's dividend payments have been increasing.
Dividend Yield vs Market
| T2 Biosystems Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (TTOO) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.5% |
| Industry Average (Biotechs) | 2.5% |
| Analyst forecast (TTOO) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate TTOO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate TTOO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate TTOO's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as TTOO has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/29 02:45 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
T2 Biosystems, Inc. is covered by 10 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Benjamin Haynor | Alliance Global Partners |
| Karen Koski | BTIG |
| Kyle Mikson | Canaccord Genuity |